CHRONIC KIDNEY INSUFFICIENCY

Clinical trials for CHRONIC KIDNEY INSUFFICIENCY explained in plain language.

Never miss a new study

Get alerted when new CHRONIC KIDNEY INSUFFICIENCY trials appear

Sign up with your email to follow new studies for CHRONIC KIDNEY INSUFFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug aims to tame dangerous inflammation in kidney patients

Disease control Completed

This study tested a new drug, TOUR006, designed to lower a key marker of inflammation (hs-CRP) in people with chronic kidney disease. Researchers wanted to see if giving the drug monthly or quarterly was safe and effective at reducing this inflammation. The goal is to see if cont…

Matched conditions: CHRONIC KIDNEY INSUFFICIENCY

Phase: PHASE2 • Sponsor: Tourmaline Bio, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

CHRONIC KIDNEY INSUFFICIENCY

Get alerted when new CHRONIC KIDNEY INSUFFICIENCY trials appear

New drug aims to tame dangerous inflammation in kidney patients